4th Annual Clinical Development & Trials Asia Congress

27th & 28th January 2015
Shanghai, China

Attend Oxford Global Conferences’ 4th Annual Clinical Development and Trials Asia Congress, and hear over 40 presentations, case studies and panel discussions delivered by leading biotech companies, global pharma organisations & internationally renowned academic institutions.
 
Do not miss out on the main themes of the event in 2015:
• Regulatory Updates in the China and impact on Multinational drug development activities
• Registration for multinational clinical trials in different therapeutic areas
• Key developments in Regional and global clinical trial activities & clinical research outsourcing strategies
• Enabling technologies in managing clinical development, implementing Biomarkers into clinical research and developing diagnostics for Clinical Trials
• Clinical trial management strategies in minimising costs, managing supply chain, optimizing CRO partnerships,
• Accelerating clinical trial timelines and bridging studies in Asia for Global Development.

14 prescheduled one to one meetings, exhibition spaces and informal networking opportunities
 
Oxford Global Conferences are proud to present the 4th Annual Clinical Development and Trials Asia Congress and co-located Pharma R&D Asia Congress to be held on the 27th & 28th January 2015 in Shanghai, China.
 
Attended by over 170 industry leaders, the 4th Annual Clinical Development and Trials Asia Congress will offer invaluable insights into the changing regulatory environment in China and surrounding regions and cover successful strategies and innovative technologies in enabling clinical development and clinical trial management.
 
On Day One, hear from senior speakers covering key discussions on the changing regulatory environment in China and impact of this on multinational drug development activities, as well as updates on registration for multinational clinical trials.  Also, do not miss out on optimising clinical development strategies in oncology and other therapeutic areas from China, Japan, South Korea, India, & Singapore.
There is a featured enabling technologies stream on day one, dedicated to managing Clinical Development, implementing Biomarkers into clinical research and developing diagnostics for Clinical Trials.
 
On Day Two, the innovative programme will cover the key operational, logistical, and regulatory aspects of conducting clinical trials in China and other Asian countries. It will focus on Clinical Trial Management strategies for minimising costs, managing supply chain, CRO partnerships in accelerating clinical trial timelines and bridging studies in Asia for Global Development.
 
Do not miss out on our co-located 5th Annual Pharma R&D World Asia Congress, which will consist of case studies in novel scientific innovations in Discovery and Development in Asia. The dynamics of outsourcing has changed dramatically over these few years, and CROs are emerging as strategic drug development partners. Key global collaboration projects, changes in the model of CRO outsourcing & partnering strategies are discussed here, along with how pharm companies adapt to changes in regulation policies and optimise in licensing opportunities.

On Day Two, our esteemed experts will cover strategies to accelerate drug development timelines. The topics include the latest drug innovation and development activities in improving productivity in Asia.
 
To view the agenda and full list of speakers and presentations, please visit http:///download-agenda-marketing/
 
For further information and to enquire about available discounts, please contact Steph Punfield on s.punfield@oxfordglobal.co.uk  or call +44 (0)1865 248455.